TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31401929

Group type: EXPERIMENTAL
Intervention: Intraoperative digital dilatation of cervix
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-cervical dilatation
Number of subjects: 0
Study: 31912780

Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate
Number of subjects: 1107
Study: 28029317

Group type: EXPERIMENTAL
Intervention: Diagnostic laparoscopy
Number of subjects: 201

Group type: COMPARATOR
Intervention: Primary surgery
Number of subjects: 201
Study: 26166533

Group type: EXPERIMENTAL
Intervention: Modified Gow‐Gates technique
Number of subjects: 206

Group type: COMPARATOR
Intervention: Halstead technique
Number of subjects: 206
Study: 23464658

Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia with propofol and remifentanil (TIVA)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Inhalational sevoflurane anesthesia (SEVO)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Subjects experiencing ED
Number of subjects: 112
Study: 21095134

Group type: EXPERIMENTAL
Intervention: Transit-time flow measurement (TTFM)
Number of subjects: 75
Study: 19342206

Group type: EXPERIMENTAL
Intervention: Zolmitriptan 7.5 mg/d
Number of subjects: 33

Group type: COMPARATOR
Intervention: Propranolol 120 mg/d
Number of subjects: 33
Study: 17618080

Group type: EXPERIMENTAL
Intervention: Nurse‐assisted symptom management (NASM)
Number of subjects: 435

Group type: EXPERIMENTAL
Intervention: Automated telephone symptom management (ATSM)
Number of subjects: 435
Study: 15377579

Group type: EXPERIMENTAL
Intervention: Ropivacaine 2 mg ml(‐1) and fentanyl 5 microg ml(‐1) with clonidine 2 microg ml(‐1) (Group RFC)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Ropivacaine 2 mg ml(‐1) and fentanyl 5 microg ml(‐1) without clonidine (Group RF)
Number of subjects: 69
Study: 11593098

Group type: EXPERIMENTAL
Intervention: Irbesartan
Number of subjects: 86

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 86
Study: 9702404

Group type: EXPERIMENTAL
Intervention: Infusional high-dose 5-fluorouracil (5-FU)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined treatment modality (surgery + chemotherapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postoperative adjuvant chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intraperitoneal postoperative treatment
Number of subjects: 0
Study: 7991724

Group type: COMPARATOR
Intervention: Placebo control condition
Number of subjects: 0
Study: 2660473

Group type: EXPERIMENTAL
Intervention: Metronidazole prophylaxis (n = 172)
Number of subjects: 376

Group type: COMPARATOR
Intervention: Control group (n = 204)
Number of subjects: 376
Study: 31034580

Group type: EXPERIMENTAL
Intervention: Verum ear acupuncture plus standard obstetric care
Number of subjects: 220
Study: 28523987

Group type: EXPERIMENTAL
Intervention: Early provision of ankle-foot orthosis (at inclusion; week 1)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Delayed provision of ankle-foot orthosis (eight weeks later; week 9)
Number of subjects: 33
Study: 24659472

Group type: EXPERIMENTAL
Intervention: Tissue-tolerable plasma (TTP)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Octenidine dihydrochloride (ODC)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Combination of TTP and ODC
Number of subjects: 34
Study: 23512821

Group type: EXPERIMENTAL
Intervention: SenseWear armband (SWA) Pro 2, version SWA 5.1
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: SenseWear armband (SWA) Pro 2, version SWA 6.1
Number of subjects: 62
Study: 22092477

Group type: EXPERIMENTAL
Intervention: Low intensity laser therapy (LILT) applied with a diode laser (588 nm) before and immediately after surgery, and for 5 min daily for 7 days post-operatively
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (no LILT)
Number of subjects: 10
Study: 18400982

Group type: EXPERIMENTAL
Intervention: Once-daily oral methylphenidate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transdermal methylphenidate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17701685

Group type: EXPERIMENTAL
Intervention: Chronotherapeutic strategies (timed administration of antihypertensive medication)
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: Chronotherapeutic strategies
Number of subjects: 3000
Study: 14980748

Group type: EXPERIMENTAL
Intervention: Usual medical care plus intensive intervention implemented by a nurse case manager (NCM)/community health worker (CHW) team
Number of subjects: 542

Group type: COMPARATOR
Intervention: Usual medical care plus minimal telephone intervention implemented by a trained lay health educator
Number of subjects: 542
Study: 12202673

Group type: EXPERIMENTAL
Intervention: Oral clodronate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous pamidronate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous zoledronic acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous pamidronate or zoledronic acid
Number of subjects: 0
Study: 9524044

Group type: EXPERIMENTAL
Intervention: Trandolapril 2 mg once daily
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Perindopril 4 mg once daily
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo after drug discontinuation
Number of subjects: 119
Study: 16353582

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 1026

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1026
Study: 2767910

Group type: EXPERIMENTAL
Intervention: Planned play periods (four periods)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Regular ward stimuli (control group)
Number of subjects: 60
Study: 336648

Group type: EXPERIMENTAL
Intervention: Transcendental Meditation (TM) technique, practiced twice daily for 2 weeks
Number of subjects: 33

Group type: COMPARATOR
Intervention: Passive relaxation, practiced twice daily for 2 weeks
Number of subjects: 33
Study: 31785830

Group type: EXPERIMENTAL
Intervention: Synchronous chemo-radiotherapy
Number of subjects: 2297

Group type: COMPARATOR
Intervention: Sequential chemo-radiotherapy
Number of subjects: 2297

Group type: EXPERIMENTAL
Intervention: Synchronous chemo-radiotherapy (anthracycline-CMF subgroup)
Number of subjects: 2297

Group type: COMPARATOR
Intervention: Sequential chemo-radiotherapy (anthracycline-CMF subgroup)
Number of subjects: 2297
Study: 29272072

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Endurance Training (END)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 29
Study: 25969453

Group type: EXPERIMENTAL
Intervention: Counseling intervention of up to 12 weeks to support smoking reduction and increased physical activity
Number of subjects: 99

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 99
Study: 24568299

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Physical Therapy
Number of subjects: 320

Group type: COMPARATOR
Intervention: Education
Number of subjects: 320
Study: 22339103

Group type: EXPERIMENTAL
Intervention: HRV‐BF
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Slow abdominal breathing
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 43
Study: 20033621

Group type: EXPERIMENTAL
Intervention: Commercial EMRs
Number of subjects: 60
Study: 17495198

Group type: EXPERIMENTAL
Intervention: Higher protein-acute meal (HP-AM)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Normal protein-acute meal (NP-AM)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Higher protein-chronic diet (HP-CD)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Normal protein-chronic diet (NP-CD)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Higher protein-acute meal (HP-AM) in HP-CD
Number of subjects: 38

Group type: COMPARATOR
Intervention: Normal protein-acute meal (NP-AM) in NP-CD
Number of subjects: 38
Study: 16213322

Group type: EXPERIMENTAL
Intervention: Calcitriol therapy (group 1, n = 57)
Number of subjects: 110
Study: 12165477

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Anticholinergic drug (0.4 mg iv scopolamine)
Number of subjects: 0
Study: 9885795

Group type: EXPERIMENTAL
Intervention: m-CPP (0.4 mg/kg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: ipsapirone (0.3 mg/kg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: m-CPP or ipsapirone
Number of subjects: 24

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 24
Study: 8736278

Group type: EXPERIMENTAL
Intervention: Turner's syndrome
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Other forms of primary amenorrhoea
Number of subjects: 120

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 120
Study: 2044333

Group type: EXPERIMENTAL
Intervention: Flumazenil infusion at 10 micrograms/L
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Flumazenil infusion at 20 micrograms/L
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Flumazenil infusion
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Midazolam infusion
Number of subjects: 8
Study: 7345027

Group type: EXPERIMENTAL
Intervention: Empathy training
Number of subjects: 28

Group type: COMPARATOR
Intervention: Discussion control group
Number of subjects: 28

Group type: COMPARATOR
Intervention: Testing control group
Number of subjects: 28
Study: 31168863

Group type: EXPERIMENTAL
Intervention: Activity breaks and mathematics combined
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Activity breaks
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control
Number of subjects: 87
Study: 30797389

Group type: EXPERIMENTAL
Intervention: Happiness exercises (5 brief self-administered exercises)
Number of subjects: 531

Group type: EXPERIMENTAL
Intervention: Reliving Happy Moments exercise
Number of subjects: 531

Group type: EXPERIMENTAL
Intervention: Savoring exercise
Number of subjects: 531

Group type: EXPERIMENTAL
Intervention: Rose, Thorn, Bud exercise
Number of subjects: 531

Group type: EXPERIMENTAL
Intervention: 3 Good Things exercise
Number of subjects: 531

Group type: COMPARATOR
Intervention: 3 Hard Things exercise
Number of subjects: 531
Study: 28459989

Group type: EXPERIMENTAL
Intervention: Experimental intervention (EX): Usual care (nutrition and PA education materials) plus 2‐month supervised weekly physical activity and behaviour change sessions.
Number of subjects: 112

Group type: COMPARATOR
Intervention: Usual care (UC): Nutrition and PA education materials.
Number of subjects: 112
Study: 25877812

Group type: EXPERIMENTAL
Intervention: Calorie Restriction (CR)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Exercise (EX)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Calorie Restriction and Exercise (CREX)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control (CR and EX)
Number of subjects: 52
Study: 23624641

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 146

Group type: COMPARATOR
Intervention: Naltrexone (opioid blockade)
Number of subjects: 146
Study: 22922846

Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab (IVR)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Intravitreal bevacizumab (IVB)
Number of subjects: 55
Study: 20671330

Group type: EXPERIMENTAL
Intervention: Relaxation-guided imagery (R-GI)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Usual-care (UC)
Number of subjects: 59
Study: 17244232

Group type: EXPERIMENTAL
Intervention: Nociceptive trigeminal inhibitory (NTI) splint
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard flat occlusal splint (OS)
Number of subjects: 10
Study: 14964925

Group type: EXPERIMENTAL
Intervention: Intervention targeting rural providers and their practice environment
Number of subjects: 881

Group type: COMPARATOR
Intervention: Control group (not specified intervention)
Number of subjects: 881
Study: 11461772

Group type: EXPERIMENTAL
Intervention: Vitamin E (400 IU) + Vitamin C (1000 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Vitamin E (400 IU) alone
Number of subjects: 20
Study: 9492719

Group type: EXPERIMENTAL
Intervention: Methylergometrine 0.125 mg three times a day for three days
Number of subjects: 217

Group type: COMPARATOR
Intervention: Placebo three times a day for three days
Number of subjects: 217
Study: 7984652

Group type: EXPERIMENTAL
Intervention: 10% naproxen gel
Number of subjects: 64

Group type: COMPARATOR
Intervention: 1% diclophenac gel
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 64
Study: 3378552

Group type: EXPERIMENTAL
Intervention: Tactile method
Number of subjects: 33

Group type: COMPARATOR
Intervention: Visual method
Number of subjects: 33

Group type: COMPARATOR
Intervention: Spring method
Number of subjects: 33
Study: 29221795

Group type: EXPERIMENTAL
Intervention: Tramadol hydrochloride 25 mg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Lidocaine hydrochloride 20 mg
Number of subjects: 50
Study: 28564127

Group type: EXPERIMENTAL
Intervention: Terlipressin (1-4 μg/kg/h) for 5 days
Number of subjects: 50

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 50
Study: 25443279

Group type: EXPERIMENTAL
Intervention: ProRoot MTA
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Endocem
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 46

Group type: COMPARATOR
Intervention: Comparison between ProRoot MTA and Endocem
Number of subjects: 46
Study: 22864764

Group type: EXPERIMENTAL
Intervention: Abdominal sacrocolpopexy (ASCP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laparoscopic sacrocolpopexy (LSCP)
Number of subjects: 0
Study: 17138275

Group type: EXPERIMENTAL
Intervention: Contraction pattern with random directional pattern in 3-month-olds
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Expansion pattern with random directional pattern in 3-month-olds
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Expansion/contraction patterns in 2-month-olds
Number of subjects: 2
Study: 15055413

Group type: EXPERIMENTAL
Intervention: Care recommendation (CR) letter intervention
Number of subjects: 188
Study: 10686803

Group type: EXPERIMENTAL
Intervention: High doses of lisinopril (32.5-35 mg/daily)
Number of subjects: 3164

Group type: COMPARATOR
Intervention: Low doses of lisinopril (2.5-5 mg/daily)
Number of subjects: 3164
Study: 8705223

Group type: EXPERIMENTAL
Intervention: Flutamide
Number of subjects: 222

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 222
Study: 1912370

Group type: EXPERIMENTAL
Intervention: Bestatin immunotherapy combined with remission maintenance chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bestatin immunotherapy
Number of subjects: 0
Study: 6125181

Group type: EXPERIMENTAL
Intervention: Pindolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 0
Study: 31096780

Group type: EXPERIMENTAL
Intervention: Supporting Teens with Autism on Relationships program (interventionist‐led parent group)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Supporting Teens with Autism on Relationships program (parent self‐guided)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Attentional control group (substance abuse prevention program)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Supporting Teens with Autism on Relationships program (both groups)
Number of subjects: 84
Study: 31538590

Group type: EXPERIMENTAL
Intervention: DHA + AA supplementation (200 mg DHA + 200 mg AA daily for 180 days)
Number of subjects: 377

Group type: COMPARATOR
Intervention: Placebo (400 mg corn oil daily for 180 days)
Number of subjects: 377
Study: 27269294

Group type: EXPERIMENTAL
Intervention: Cx611 (1 million/kg)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Cx611 (2 million/kg)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Cx611 (4 million/kg)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 25445156

Group type: EXPERIMENTAL
Intervention: IG-IMRT
Number of subjects: 18

Group type: COMPARATOR
Intervention: 3D-CRT
Number of subjects: 18

Group type: COMPARATOR
Intervention: SBRT (positive control)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: All participants
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Doses ≥ 35 Gy
Number of subjects: 18
Study: 23829690

Group type: EXPERIMENTAL
Intervention: Latina-targeted Pap smear and mammogram public service announcements
Number of subjects: 1419

Group type: COMPARATOR
Intervention: General-market messages
Number of subjects: 1419
Study: 21745533

Group type: EXPERIMENTAL
Intervention: Adrenaline 1:1000
Number of subjects: 534

Group type: COMPARATOR
Intervention: Placebo (sodium chloride 0.9%)
Number of subjects: 534
Study: 19934912

Group type: EXPERIMENTAL
Intervention: Goal-directed/lactated Ringer's
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Goal-directed/hetastarch
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard
Number of subjects: 64
Study: 16412747

Group type: EXPERIMENTAL
Intervention: Oral estrogen therapy (0.625 mg of conjugated equine E per tablet; n = 27)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Topical estrogen therapy (0.625 mg conjugated equine E per 1 g vaginal cream; n = 30)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Oral estrogen therapy
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Topical estrogen therapy
Number of subjects: 57
Study: 15326115

Group type: COMPARATOR
Intervention: Silicone hydrogel contact lens
Number of subjects: 20

Group type: COMPARATOR
Intervention: Hyper-Dk rigid contact lens
Number of subjects: 20

Group type: COMPARATOR
Intervention: Rubbing one eye
Number of subjects: 20
Study: 11424305

Group type: EXPERIMENTAL
Intervention: Computer-based nursing documentation system (PIK group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Paper-based system (control group)
Number of subjects: 60
Study: 9690480

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH, dalteparin, Fragmin) once daily for 5 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH, dalteparin, Fragmin) once daily for 7 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo following a 1-week LMWH treatment (once daily)
Number of subjects: 0
Study: 8506906

Group type: EXPERIMENTAL
Intervention: Single running suture (24-bite 10-0 nylon suture)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Combined running and interrupted sutures (16-bite running 10-0 nylon suture and eight interrupted 10-0 nylon sutures)
Number of subjects: 38
Study: 3319640

Group type: EXPERIMENTAL
Intervention: Nicardipine 30 mg t.d.s.
Number of subjects: 22

Group type: COMPARATOR
Intervention: Propranolol 80 mg t.d.s.
Number of subjects: 22
Study: 27251578

Group type: EXPERIMENTAL
Intervention: GMT+Lifelog
Number of subjects: 16

Group type: COMPARATOR
Intervention: GMT
Number of subjects: 16
Study: 27403851

Group type: EXPERIMENTAL
Intervention: l-Tyrosine (TYR) supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 0
Study: 25060669

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Other NSAIDs
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 699
Study: 23609389

Group type: EXPERIMENTAL
Intervention: Almorexant 100 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Almorexant 200 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Almorexant 400 mg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36

Group type: COMPARATOR
Intervention: Zolpidem 10 mg
Number of subjects: 36
Study: 20508184

Group type: EXPERIMENTAL
Intervention: Auto-titrating continuous positive airway pressure (auto-CPAP) for 2 nights, continued for 90 days for those with sleep apnea.
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group received polysomnography at baseline and at 90 days without auto-CPAP.
Number of subjects: 70
Study: 18211277

Group type: EXPERIMENTAL
Intervention: Personality-targeted intervention
Number of subjects: 368

Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 368
Study: 16380825

Group type: EXPERIMENTAL
Intervention: Induced emotions (joy, anger, disgust)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Induced emotions (disgust)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Induced emotions (fear/anxiety)
Number of subjects: 30
Study: 12725663

Group type: EXPERIMENTAL
Intervention: Transdermal estrogen (50 microg estradiol patch weekly)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Transdermal estrogen
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Normal patients (healthy women)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Women with coronary disease
Number of subjects: 27
Study: 10961865

Group type: EXPERIMENTAL
Intervention: CsA and MTX
Number of subjects: 71

Group type: COMPARATOR
Intervention: CsA alone
Number of subjects: 71
Study: 8615489

Group type: EXPERIMENTAL
Intervention: Intraoperative ketorolac 60 mg i.v. with fentanyl 2 micrograms/kg i.v.
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control group (saline 2 mL) with fentanyl 2 micrograms/kg i.v.
Number of subjects: 126
Study: 1288967

Group type: EXPERIMENTAL
Intervention: Ceftriaxone alone
Number of subjects: 284

Group type: COMPARATOR
Intervention: Ceftriaxone plus amikacin
Number of subjects: 284
Study: 6327784

Group type: EXPERIMENTAL
Intervention: Ketoconazole (200 mg daily for 4 weeks)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Ketoconazole (follow-up after 1 year)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo (followed by topical imidazole)
Number of subjects: 66
Study: 31215270

Group type: EXPERIMENTAL
Intervention: Mifepristone combined with misoprostol
Number of subjects: 25

Group type: COMPARATOR
Intervention: Misoprostol alone
Number of subjects: 25

Group type: COMPARATOR
Intervention: Expectant management or surgical intervention
Number of subjects: 25
Study: 30235704

Group type: EXPERIMENTAL
Intervention: Fluoroscopy-guided acupuncture
Number of subjects: 57

Group type: COMPARATOR
Intervention: Acupuncture without fluoroscopy
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Both groups (Fluoroscopy-guided acupuncture and Acupuncture without fluoroscopy)
Number of subjects: 57